Home › Inflammatory Bowel Disease › NCT06309017

Pre-operative Nutrition for Elective Resection Surgery in Inflammatory Bowel Disease

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

1. Able and willing to provide written informed consent
2. Aged 18 years of age or older
3. Confirmed diagnosis of inflammatory bowel disease
4. Scheduled for disease-related intestinal resection at NYU Langone Health

Exclusion Criteria:

1. No current diagnosis of inflammatory bowel disease
2. Age less than 18
3. Not proficient (able to read and answer questions) in English

About the study

This study aims to determine if improved risk stratification tools and interventions to mitigate malnutrition reduce postoperative risk in patients undergoing elective or emergent resection surgery for inflammatory bowel disease (IBD), and if adding immune modulation nutrition improves surgical outcomes. The primary objective is to assess whether preoperative malnutrition screening and intervention minimize postoperative complications. The secondary objective is to evaluate whether immune modulation nutrition in the peri-operative period decreases length of stay and major complications.

What is being tested

• Nutrition specialist (other)
• Ensure Surgery Immunonutrition shakes (dietary supplement)

Sponsor: NYU Langone Health · Participants: 150 · Started: Jan 7, 2025

Contact the study team

• Jennifer Katz, MD · Phone: (855) 698-4232

Official record on ClinicalTrials.gov — NCT06309017

Locations in the U.S.

Conditions

• Inflammatory Bowel Disease

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.